Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?

Timothy H Harries,1 Gill Gilworth,1 Christopher J Corrigan,2 Patrick B Murphy,3 Nicholas Hart,3 Mike Thomas,4 Patrick T White1 1Department of Public Health and Primary Care, School of Population Health and Environmental Sciences, King’s College London, London, UK; 2Department of Asthma All...

Full description

Bibliographic Details
Main Authors: Harries TH, Gilworth G, Corrigan CJ, Murphy PB, Hart N, Thomas M, White PT
Format: Article
Language:English
Published: Dove Medical Press 2020-01-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/inhaled-corticosteroids-prescribed-for-copd-patients-with-mild-or-mode-peer-reviewed-article-COPD
_version_ 1818254079720161280
author Harries TH
Gilworth G
Corrigan CJ
Murphy PB
Hart N
Thomas M
White PT
author_facet Harries TH
Gilworth G
Corrigan CJ
Murphy PB
Hart N
Thomas M
White PT
author_sort Harries TH
collection DOAJ
description Timothy H Harries,1 Gill Gilworth,1 Christopher J Corrigan,2 Patrick B Murphy,3 Nicholas Hart,3 Mike Thomas,4 Patrick T White1 1Department of Public Health and Primary Care, School of Population Health and Environmental Sciences, King’s College London, London, UK; 2Department of Asthma Allergy and Respiratory Science, King’s College London, London, UK; 3Lane Fox Respiratory Unit, Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London, London, UK; 4Primary Care and Population Medicine, University of Southampton, Southampton, UKCorrespondence: Timothy H HarriesDepartment of Public Health and Primary Care, School of Population Health and Environmental Sciences, King’s College London 3rd Floor Addison House, Guys Campus, London SE1 1UL, UKTel +44 20 7836 5454Email timothy.harries@kcl.ac.ukAbstract: COPD patients prescribed inhaled corticosteroids (ICS) outside guidelines should be targeted for ICS withdrawal. Within a primary care population of 209,618 we used a combination of digital search algorithm, individual record review, and clinical review to identify COPD patients suitable for a trial of ICS withdrawal. At most, 39% of COPD patients with mild or moderate airflow limitation prescribed ICS were suitable for withdrawal according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Recurrent exacerbations and reversible airway obstruction were the main reasons for patients’ unsuitability for withdrawal. Identifying COPD patients in whom ICS withdrawal should be considered presents a challenge to primary care clinicians.Keywords: pulmonary disease, chronic obstructive, inhaled corticosteroids, drug withdrawal, mild airflow limitation, moderate airflow limitation
first_indexed 2024-12-12T16:50:16Z
format Article
id doaj.art-6940c306755746f987ecd550cbcd5def
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-12T16:50:16Z
publishDate 2020-01-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-6940c306755746f987ecd550cbcd5def2022-12-22T00:18:23ZengDove Medical PressInternational Journal of COPD1178-20052020-01-01Volume 143063306650854Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?Harries THGilworth GCorrigan CJMurphy PBHart NThomas MWhite PTTimothy H Harries,1 Gill Gilworth,1 Christopher J Corrigan,2 Patrick B Murphy,3 Nicholas Hart,3 Mike Thomas,4 Patrick T White1 1Department of Public Health and Primary Care, School of Population Health and Environmental Sciences, King’s College London, London, UK; 2Department of Asthma Allergy and Respiratory Science, King’s College London, London, UK; 3Lane Fox Respiratory Unit, Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London, London, UK; 4Primary Care and Population Medicine, University of Southampton, Southampton, UKCorrespondence: Timothy H HarriesDepartment of Public Health and Primary Care, School of Population Health and Environmental Sciences, King’s College London 3rd Floor Addison House, Guys Campus, London SE1 1UL, UKTel +44 20 7836 5454Email timothy.harries@kcl.ac.ukAbstract: COPD patients prescribed inhaled corticosteroids (ICS) outside guidelines should be targeted for ICS withdrawal. Within a primary care population of 209,618 we used a combination of digital search algorithm, individual record review, and clinical review to identify COPD patients suitable for a trial of ICS withdrawal. At most, 39% of COPD patients with mild or moderate airflow limitation prescribed ICS were suitable for withdrawal according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Recurrent exacerbations and reversible airway obstruction were the main reasons for patients’ unsuitability for withdrawal. Identifying COPD patients in whom ICS withdrawal should be considered presents a challenge to primary care clinicians.Keywords: pulmonary disease, chronic obstructive, inhaled corticosteroids, drug withdrawal, mild airflow limitation, moderate airflow limitationhttps://www.dovepress.com/inhaled-corticosteroids-prescribed-for-copd-patients-with-mild-or-mode-peer-reviewed-article-COPDpulmonary diseasechronic obstructiveinhaled corticosteroidsdrug withdrawalmild airflow limitationmoderate airflow limitation
spellingShingle Harries TH
Gilworth G
Corrigan CJ
Murphy PB
Hart N
Thomas M
White PT
Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
International Journal of COPD
pulmonary disease
chronic obstructive
inhaled corticosteroids
drug withdrawal
mild airflow limitation
moderate airflow limitation
title Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
title_full Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
title_fullStr Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
title_full_unstemmed Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
title_short Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
title_sort inhaled corticosteroids prescribed for copd patients with mild or moderate airflow limitation who warrants a trial of withdrawal
topic pulmonary disease
chronic obstructive
inhaled corticosteroids
drug withdrawal
mild airflow limitation
moderate airflow limitation
url https://www.dovepress.com/inhaled-corticosteroids-prescribed-for-copd-patients-with-mild-or-mode-peer-reviewed-article-COPD
work_keys_str_mv AT harriesth inhaledcorticosteroidsprescribedforcopdpatientswithmildormoderateairflowlimitationwhowarrantsatrialofwithdrawal
AT gilworthg inhaledcorticosteroidsprescribedforcopdpatientswithmildormoderateairflowlimitationwhowarrantsatrialofwithdrawal
AT corrigancj inhaledcorticosteroidsprescribedforcopdpatientswithmildormoderateairflowlimitationwhowarrantsatrialofwithdrawal
AT murphypb inhaledcorticosteroidsprescribedforcopdpatientswithmildormoderateairflowlimitationwhowarrantsatrialofwithdrawal
AT hartn inhaledcorticosteroidsprescribedforcopdpatientswithmildormoderateairflowlimitationwhowarrantsatrialofwithdrawal
AT thomasm inhaledcorticosteroidsprescribedforcopdpatientswithmildormoderateairflowlimitationwhowarrantsatrialofwithdrawal
AT whitept inhaledcorticosteroidsprescribedforcopdpatientswithmildormoderateairflowlimitationwhowarrantsatrialofwithdrawal